Evidence map›Paper›PMID 29417373›Full record

ReviewEndocrine2018

Practical issues for the management of hyponatremia in oncology.

Rossana Berardi, Andrea Antonuzzo, Livio Blasi, Roberta Buosi, Vito Lorusso, Maria Rita Migliorino, Vincenzo Montesarchio, Nicoletta Zilembo, Roberto Sabbatini, Alessandro Peri

Abstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. The VJournal of endocrinological investigation · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Evidence for Effective Multiple KFrontiers in pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rossana BerardiUniversità Politecnica delle Marche, Azienda Ospedaliero-Universitaria, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, via Conca 71, Ancona, 60126, Italy.
Andrea AntonuzzoUnit of Medical Oncology 1, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori Pisa, Via Roma 67, Pisa, PI, 56126, Italy.
Livio BlasiMedical Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.
Roberta BuosiDepartment of Medical Oncology, Ospedale Santo Spirito, Via Giovanni Giolitti 2, Casale Monferrato, AL, 15033, Italy.
Vito LorussoDepartment of Medical Oncology, National Cancer Research Centre "Giovanni Paolo II", Via Samuel F. Hahnemann 10, Bari, 70126, Italy.
Maria Rita MigliorinoFirst Oncological Pulmonary Unit, San Camillo, High Specialization Hospital, Circonvallazione Gianicolense 87, Roma, RM, 00152, Italy.
Vincenzo MontesarchioUnit of Oncology, A.O.R.N. dei Colli "Ospedali Monaldi-Cotugno-CTO", Via Gaetano Quagliariello 54, Napoli, Italy.
Nicoletta ZilemboFondazione IRCCS Istituto Nazionale dei Tumori, Medical Oncology 1, via Venezian 1, Milano, MI, 20133, Italy.
Roberto SabbatiniDepartment of Oncology and Haematology, AOU Policlinico di Modena, Via del Pozzo 71, Modena, MO, 41124, Italy.
Alessandro PeriEndocrine Unit, Department of Experimental and Biomedical Sciences "Mario Serio", Center for Research, Transfer and Higher Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies, University of Florence, Viale Pieraccini 6, Florence, 20139, Italy. alessandro.peri@unifi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyponatremia is common in cancer patients and has a negative impact on outcomes and survival. Both the diagnosis and treatment of hyponatremia are challenging. Easy-to-use, practical guidelines are needed. The aim of this article is to discuss practical issues related to the diagnostic workup and management of hyponatremia, with particular attention to complex patients, such as those affected by neoplastic diseases. Admittedly, these patients may present several comorbidities, which may cause sodium alterations. In addition, multidrug therapy may precipitate serum sodium fall. An algorithm for the diagnosis and treatment of hyponatremia was also developed, based on the discussion of the results of a questionnaire completed by the authors and of the published recommendations/guidelines on hyponatremia. The goal was to produce an algorithm that was as simple as possible but still comprehensive, without compromising information completeness. Many explanatory notes were added with the aim of guiding clinicians throughout the management of complex patients with hyponatremia, such as those with cancer. The resulting algorithm and supporting literature are presented.

Indexed as

Antidiuretic Hormone Receptor AntagonistsDisease ManagementHumansHyponatremiaInappropriate ADH SyndromeNeoplasmsTolvaptanAntidiuretic Hormone Receptor AntagonistsTolvaptanAntidiuretic hormoneArginine vasopressinHyponatremiaSIADHTolvaptanWater excretion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.